Status:
COMPLETED
Adverse Events Related to Treatments Used Against Coronavirus Disease 2019
Lead Sponsor:
Groupe Hospitalier Pitie-Salpetriere
Collaborating Sponsors:
CMC Ambroise Paré
Conditions:
Coronavirus
Iatrogenic Disease
Eligibility:
All Genders
Brief Summary
The outbreak of Covid-19 started several clinical trials and treatment experiments all over the world in the first months of 2020. This study investigates reports of adverse events related to used mol...
Eligibility Criteria
Inclusion
- all patients treated for Covid-19
Exclusion
- Chronology not compatible between the drug and the toxicity
Key Trial Info
Start Date :
March 17 2020
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
January 1 2023
Estimated Enrollment :
1000 Patients enrolled
Trial Details
Trial ID
NCT04314817
Start Date
March 17 2020
End Date
January 1 2023
Last Update
April 21 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
AP-HP Assistance Publique Hopitaux de Paris
Paris, France